Literature DB >> 2673187

In vitro comparison of the activity of various antifungal drugs against new yeast isolates causing thrush in poultry.

M Y Lin1, K J Huang, S H Kleven.   

Abstract

Of 44 representative isolates of yeast isolated from the poultry upper digestive tract from 40 clinical thrush cases in Taiwan during 1985-87, 39 (89%) isolates were classified as Candida albicans, and 5 (11%) were classified as Torulopsis pintolopesii. Fifteen commercial antifungal drugs, incorporated individually in Sabouraud's dextrose agar by serial twofold dilutions, were tested for their inhibitory effect against the 44 isolates. The MIC50 of these drugs in increasing order was less than or equal to 2 ppm GV-11, 6 ppm gentian violet, less than 16 ppm amphotericin B, 16 ppm hyamine 1622, 25 ppm econazole, 35 ppm chlorohydroxyquinoline, 40 ppm nystatin, 64 ppm miconazole, 747 ppm malachite green, 1550 ppm benzoic acid, 1536 ppm copper sulfate, 3144 ppm Monoprop, 4951 ppm Mold Zap, greater than 16,384 ppm propionic acid, and greater than 16,384 ppm sodium propionate.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2673187

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  3 in total

1.  New nystatin polymeric complexes and their in vitro antifungal evaluation in a model study with Fusarium oxysporum.

Authors:  Ekatherina Charvalos; Aristeidis Tsatsakis; Manolis Tzatzarakis; George Dolapsakis; John Stiakakis
Journal:  Mycopathologia       Date:  2002       Impact factor: 2.574

Review 2.  The Use of Copper as an Antimicrobial Agent in Health Care, Including Obstetrics and Gynecology.

Authors:  Linda P Arendsen; Ranee Thakar; Abdul H Sultan
Journal:  Clin Microbiol Rev       Date:  2019-08-14       Impact factor: 26.132

3.  E-test Determination of Antifungal Susceptibility of Candida Species Isolated from Turkeys.

Authors:  Ireneusz Sokół; Stanisław Tokarzewski; Kamila Bobrek; Andrzej Gaweł
Journal:  J Vet Res       Date:  2020-11-10       Impact factor: 1.744

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.